NCT05913700View on ClinicalTrials.gov

Effect of Respiratory Virus Infection on EmeRgencY Admission Study (EVERY Study)

Active, not recruitingOBSERVATIONAL
Enrollment

3,067

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

January 22, 2025

Study Completion Date

September 30, 2026

Conditions
Respiratory Syncytial Virus (RSV)Respiratory Viral InfectionAcute Disease
Trial Locations (3)

607-8062

Rakuwakai Otowa Hospital, Kyoto

630-8305

Nara City Hospital, Nara

693-8555

Shimane Prefectural Central Hospital, Izumo

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Institute for Clinical Effectiveness, Japan

OTHER